Concepedia

Publication | Open Access

Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy

DOIFull Paper Access

17

Citations

11

References

2016

Year

Jean‐Pascal Machiels, Aline van Maanen, Jean‐Marie Vandenbulcke, Bertrand Filleul, Emmanuel Seront, Stéphanie Henry, Lionel D’Hondt, Christophe Lonchay, Stéphane Holbrechts, Petra Boegner,
The Oncologist

Abstract

This study did not meet its primary endpoint. Cabazitaxel has low activity in recurrent SCCHN.

References

YearCitations

Page 1